Ipsen (ENXTPA:IPN) announced a global collaboration and option agreement with Origami Therapeutics. The partnership focuses on developing a novel small molecule program for a rare neurodegenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results